0001567619-21-011654.txt : 20210603
0001567619-21-011654.hdr.sgml : 20210603
20210603183412
ACCESSION NUMBER: 0001567619-21-011654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210527
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rousseau Raphael
CENTRAL INDEX KEY: 0001754287
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 21994078
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone bio, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Gritstone Oncology, Inc.
DATE OF NAME CHANGE: 20151023
4
1
doc1.xml
FORM 4
X0306
4
2021-05-27
0
0001656634
Gritstone bio, Inc.
GRTS
0001754287
Rousseau Raphael
C/O GRITSTONE ONCOLOGY, INC.
5959 HORTON STREET, SUITE 300
EMERYVILLE
CA
94608
0
1
0
0
See Remarks
Common Stock
2021-05-27
4
M
0
2900
0.759
A
2900
D
Common Stock
2021-05-27
4
S
0
2900
9.0040
D
0
D
Stock Option (Right to Buy)
0.759
2021-05-27
4
M
0
2900
0
D
2027-05-17
Common Stock
2900
122426
D
Fully exercisable.
Executive Vice President and Chief Medical Officer
/s/ Rahsaan Thompson, Attorney-in-Fact for Raphael Rousseau
2021-06-03